Gerresheimer Ag · XETR:GXI
Gerresheimer — Q2 2025 Earnings Presentation
6 slides from Gerresheimer's earnings presentation, Jun 2, 2025
Slide 1: Q2 2025 Trading Update
Q2 2025 Trading Update Dietmar Siemssen Dr. Bernd Metzner
Slide 2: Disclaimer
Disclaimer This presentation may contain certain forward-looking statements, including assumptions, opinions and views of the Company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or
Slide 3: Q2 Preliminary Trading Update: Progress on Strategic Priorities But Unforeseen Headwinds Weighing on Growth & Profitability
Q2 Preliminary Trading Update: Progress on Strategic Priorities But Unforeseen Headwinds Weighing on Growth & Profitability Progress on strategic Unforeseen headwinds weighing priorities as laid out in Q1 on growth & profitability Q2 2025 1 Shifted revenues for Syringes Softness in cosmetics Prelimi
Slide 4: Guidance Update on Back of Softer Q2 / H1 2025
Guidance Update on Back of Softer Q2 / H1 2025 FY 2025 Guidance (organic; group level) Revenue Adjusted EBITDA Adj. EPS Old New Old New Old New 1-2% ~20% LDD% FY 2025 Growth Margin Decline3 1 HSD% Growth = High-Single-Digit Growth 2 Currency-adjusted 3 LDD% Decline = Low Double-Digit Decline 4
Slide 5: Soft H1 weighing on 2025; long-term growth prospects intact
Share of solutions for biologics and other HVS expected to grow and drive margin improvement in H2 Soft H1 weighing on 2025; long-term growth prospects intact Stronger H2, but not fully Action Taken compensating slow H1 growth Long-term Growth Prospects Intact in Light of Current Trading dynamic ▪ R
Slide 6: innovating for a better life
innovating for a better life
Gerresheimer — Q2 2025 Earnings Presentation on 6ix